The status of ultrasound and color doppler imaging for the early detection of ovarian carcinoma

Cancer Investigation

Volumn 15, Issue 3, 1997, Pages 265-269

  Karlan, Beth Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLOR ULTRASOUND FLOWMETRY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY; ULTRASOUND;

EID: 0030946592     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709039725     Document Type: Article

References (29)

1. NIH Consensus Development Panel: Ovarian cancer: Screening, treatment, and followup. JAMA 273:491-497, 1995.
2. Johannesson G, Geitsson G, Day N: The effect of mass screening in Iceland 1965-1974, on the incidence and mortality of cervical. Int J Cancer 21:418-425, 1978.
3. Tabar L, Gad A, Holmberg LH, et al: Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985.
4. Li S, Han H, Resnic E, et al: Advanced ovarian carcinoma: Molecular evidence of unifocal origin. Gynecol Oncol 51:21-25, 1993.
5. Tsao SW, Mok CH, Knapp RC, et al: Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 48:5-10, 1993.
6. Campbell S, Bhan V, Royston P, et al: Transabdominal ultrasound screening for early ovarian cancer. Br Med J 229:1363-1367, 1989.
7. DePriest PD, vanNagell JR, Gallion HH, et al: Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol Oncol 51:205-209, 1993.
8. Puls LE, Powell DE, DePriest PD, et al: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadeno-carcinoma. Gynecol Oncol 47:53-57; 1992.
9. Bourne TH, Campbell S, Reynolds KM, et al: Screening for early familial ovarian cancer with trans-vaginal ultrasonography and colour blood flow imaging. Br Med J 306:1025-1029, 1993.
10. DePriest PD, Shenson BS, Fried A, et al: A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 51:7-11, 1993.
11. Lerner JP, Timor-Tritsch IE, Federman A, et al: Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol 170:81-85, 1994.
12. Granberg S, Wikland M, Jansson I: Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: Criteria to be used for ultrasound evaluation. Gynecol Oncol 35:139-144, 1989.
13. Folkman J, Watson K, Ingber D, et al: Induction of angiogenesis during transition from hyper-plasia to neoplasia. Nature 339:58-61, 1989.
14. Karlan BY, Raffel LJ, Crvenkovic G, et al: A multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results. Am J Obstet Gynecol 169:494-501,1993.
15. Karlan BY, Platt LD: The current status of ultrasound and color doppler imaging in screening for ovarian cancer. Gynecol Oncol 55:S28-S33, 1994.
16. Yancik R, Gloeckler Ries L, et al: Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data. Am J Obstet Gynecol 154:639-647, 1986.
17. Kramer BS, Gohagan J, Prorok PC, et al: A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71:589-593, 1993.
18. Amos CI, Struewing JP: Genetic epidemiology of epithelial ovarian cancer. Cancer 71:566-572, 1993.
19. Kerlikowske K, Brown JS, Grady DG: Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol 80:700-707, 1992.
20. Lynch HT, Watson P, Lynch JF, et al: Hereditary ovarian cancer: Heterogeneity in age at onset. Cancer 71:573-581, 1993.
21. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
22. Futreal PA, Liu Q, Shattuck-Eidens D, et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:12-22, 1994.
23. Papadopoulos N, Nicolaides NC, Wei YF, et al: Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629, 1994.
24. Bronner CE, Baker SM, Morrison PT, et al: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:358-261, 1994.
25. Cane P, Azen C, Lopez E, et al: Tumor marker trends in asymptomatic women at risk for ovarian cancer: Relevance for ovarian cancer screening. Gynecol Oncol 57:240-245, 1995.
26. Skates SJ, Singer DE: Quantifying the potential benefit of CA-125 screening for ovarian cancer. J Clin Epidemiol 44:365-380, 1991.
27. Wardle FJ, Collins W, Pernet AL, et al: Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst 85:653-657, 1993.
28. Carlson KJ, Skates SJ, Singer DE: Screening for ovarian cancer: Recommendations and rationale. Ann Intern Med 121:141-142, 1994.
29. Karlan BY: Screening tor ovarian cancer: What are the optimal surrogate endpoints for clinical trials? J Cell Biochem 23:227-232, 1995.